Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2011
The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab
Roman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
The Journal of Biological Chemistry
|
June 25, 2003
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells
Yi-He Ling, Leonard Liebes, Yiyu Zou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2004
Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models
Yiyu Zou, Hao Fu, Sukhen Ghosh, et al.
Oncogene
|
November 26, 2002
The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway
Ka Yin Kwong, Yiyu Zou, Chi-Ping Day, et al.
Clinical Lung Cancer
|
November 11, 2010
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity
Sameer Mahesh, Ashish Saxena, Xuan Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment
Yiyu Zou, Carmen Tornos, Xuan Qiu, et al.
Oncotarget
|
January 10, 2018
TRIB2 contributes to cisplatin resistance in small cell lung cancer
Yuanxin Liang, Dong Yu, Roman Perez-Soler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2009
Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models
Yi-He Ling, Miguel Aracil, José Jimeno, et al.
Plos One
|
December 3, 2020
The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer
Yiyu Zou, Susan Fineberg, Alexander Pearlman, et al.
Clinical Lung Cancer
|
November 5, 2015
Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade Azacitidine
Xuan Qiu, Yuanxin Liang, Rani S Sellers, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2011
The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab
Roman Perez-Soler, Yiyu Zou, Tianhong Li, et al.
The Journal of Biological Chemistry
|
June 25, 2003
Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells
Yi-He Ling, Leonard Liebes, Yiyu Zou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2004
Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models
Yiyu Zou, Hao Fu, Sukhen Ghosh, et al.
Oncogene
|
November 26, 2002
The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway
Ka Yin Kwong, Yiyu Zou, Chi-Ping Day, et al.
Clinical Lung Cancer
|
November 11, 2010
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity
Sameer Mahesh, Ashish Saxena, Xuan Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment
Yiyu Zou, Carmen Tornos, Xuan Qiu, et al.
Oncotarget
|
January 10, 2018
TRIB2 contributes to cisplatin resistance in small cell lung cancer
Yuanxin Liang, Dong Yu, Roman Perez-Soler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2009
Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models
Yi-He Ling, Miguel Aracil, José Jimeno, et al.
Plos One
|
December 3, 2020
The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer
Yiyu Zou, Susan Fineberg, Alexander Pearlman, et al.
Clinical Lung Cancer
|
November 5, 2015
Toxicity and Pharmacokinetic Studies of Aerosolized Clinical Grade Azacitidine
Xuan Qiu, Yuanxin Liang, Rani S Sellers, et al.
Page
of 4